The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNPSN.L Regulatory News (NPSN)

  • There is currently no data for NPSN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NOVUS UNBUNDLING: RESULTS OF ACCELERATED BOOKBUILD

27 Sep 2017 07:30

RNS Number : 9333R
Naspers Limited
27 September 2017
 

Naspers Limited

(Incorporated in the Republic of South Africa)

Registration number: 1925/001431/06

Share code: NPN

ISIN: ZAE000015889

("Naspers" or "Company")

 

RESULTS OF THE ACCELERATED BOOKBUILD

 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE NASPERS TO TAKE ANY ACTION. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM AN OFFER OF SECURITIES IN THE UNITED STATES OR ANY OTHER JURISDICTION.

 

THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES. THE SHARES TO WHICH THIS ANNOUNCEMENT RELATES HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT. THERE WILL NOT BE A PUBLIC OFFERING OF SUCH SHARES IN THE UNITED STATES. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

RESULTS OF THE ACCELERATED BOOKBUILD

 

Further to the announcement released by Naspers on SENS on 26 September 2017 regarding the launch of an accelerated bookbuild placing (the "Placing") of Novus Holdings Limited ("Novus") shares ("Unbundled Novus Shares").

 

Naspers is pleased to announce that the Placing was successfully priced on 26 September 2017 and 35,141,309 Unbundled Novus Shares were placed with qualifying institutional investors at a price of R6.15 per ordinary share ("Placing Price").

 

The Placing Price represents a 1.3% premium to Novus' closing share price on 26 September 2017.

 

Naspers would like to thank all investors that submitted bids and participated in the Placing.

 

 

Cape Town

27 September 2017

 

Sole global coordinator, bookrunner and sponsor

Investec Bank Limited

 

Legal advisors

Glyn Marais Inc.

 

 

Disclaimer

 

This announcement is restricted and is not for release, publication or distribution, in whole or in part, directly or indirectly, in or into the United States, Australia, Canada, Japan or any other jurisdiction in which such release, publication or distribution would be unlawful or require Naspers to take any action. This announcement is for information purposes only, does not purport to be full or complete, is subject to change and shall not constitute or form part of an offer, solicitation or advertisement of an offer to purchase or subscribe for securities in the United States or any other jurisdiction. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness.

 

The Placing Shares have not been, and will not be, registered under the Securities Act, and may not be offered or sold, directly or indirectly, in the United States, absent registration or an exemption from, or transaction not subject to, the registration requirements of the Securities Act. There will be no public offer of the Shares in the United States.

 

The announcement may contain forward-looking statements as defined in the United States Private Securities Litigation Reform Act of 1995. Words such as "believe", "anticipate", "intend", "seek", "will", "plan", "could", "may", "endeavour" and similar expressions are intended to identify such forward-looking statements, but are not the exclusive means of identifying such statements. While these forward-looking statements represent our judgements and future expectations, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from our expectations. These include factors that could adversely affect our businesses and financial performance. We are not under any obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, as a result of new information, future events or otherwise. Investors are cautioned not to place undue reliance on any forward-looking statements in this announcement.

 

Neither this announcement nor the Detailed Announcement constitutes, or is intended to constitute, an offer to the public in South Africa in terms of the South African Companies Act 71 of 2008, as amended ("Companies Act"), and this announcement will not be distributed to any person in South Africa in any manner that could be construed as an offer to the public in terms of the Companies Act. In South Africa, the offer pursuant to the Capital Raising will only be made to selected persons in South Africa who fall within one of the specified categories listed in section96(1)(a) of the Companies Act. These materials do not constitute a prospectus registered and/or issued in terms of the Companies Act.

 

In member states of the European Economic Area ("EEA") which have implemented the Prospectus Directive (each, a "Relevant Member State"), this announcement and any offer if made subsequently is directed exclusively at persons who are "qualified investors" within the meaning of the Prospectus Directive ("Qualified Investors"). For these purposes, the expression "Prospectus Directive" means Directive 2003/71/EC (and amendments thereto, including Directive 2010/73/EU, to the extent implemented in a Relevant Member State), and includes any relevant implementing measure in the Relevant Member State.

 

In the United Kingdom this announcement is only directed at, and any investment or investment activity to which this announcement relates is available only to, and will be engaged in only with, Qualified Investors who are (i) investment professionals falling with Article 19(5) of the UK Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (ii) high net worth entities, or other persons to whom it may otherwise be lawfully communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as "relevant persons"). Persons who are not relevant persons should not take any action on the basis of this announcement and should not act or rely on it.

 

This announcement has been issued by, and is the sole responsibility, of Naspers. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by Investec or by any of their respective affiliates or agents as to, or in relation to, the accuracy or completeness of this announcement or any other written or oral information made available, or publicly available, to any interested party or its advisers, and any liability therefore is expressly disclaimed.

 

This announcement does not purport to identify or suggest the risks (direct or indirect) which may be associated with an investment in the Placing Shares. No representation or warranty is made by Naspers or Investec in connection with the Placing Shares or Naspers, and any investment decision to apply for Placing Shares must be made solely on the basis of publicly available information, which information has not been independently verified.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQDLBLDKFLBBB
Date   Source Headline
13th Jan 20229:30 amRNSIssue of Debt
11th Jan 20223:15 pmRNSTransaction in Own Shares
7th Jan 20227:00 amRNSDirector/PDMR Shareholding
4th Jan 20223:15 pmRNSTransaction in Own Shares
29th Dec 20217:00 amRNSTransaction in Own Shares
21st Dec 20213:15 pmRNSTransaction in Own Shares
20th Dec 20217:00 amRNSDirectorate Change
20th Dec 20217:00 amRNSDirectorate Change
14th Dec 20213:15 pmRNSTransaction in Own Shares
13th Dec 20213:15 pmRNSNotice of Intention to Delist ADSs from the LSE
7th Dec 20213:15 pmRNSTransaction in Own Shares
30th Nov 20213:15 pmRNSTransaction in Own Shares
25th Nov 20213:30 pmRNSTreasury Stock
23rd Nov 20213:15 pmRNSTransaction in Own Shares
22nd Nov 20217:00 amRNSHalf-year Report
22nd Nov 20217:00 amRNSHalf-year Report
16th Nov 20213:15 pmRNSTransaction in Own Shares
16th Nov 20217:00 amRNSTrading Statement
16th Nov 20217:00 amRNSTrading Statement
9th Nov 20213:15 pmRNSTransaction in Own Shares
2nd Nov 20213:15 pmRNSTransaction in Own Shares
26th Oct 20214:15 pmRNSTransaction in Own Shares
22nd Oct 20211:30 pmRNSClarificatory statement re dividend
21st Oct 20217:50 amRNSClarificatory statement re dividend
19th Oct 20214:15 pmRNSTransaction in Own Shares
12th Oct 20214:15 pmRNSTransaction in Own Shares
5th Oct 20214:15 pmRNSTransaction in Own Shares
4th Oct 20214:50 pmRNSStatement re Delivery Hero transaction
4th Oct 20214:50 pmRNSStatement re Delivery Hero transaction
1st Oct 20217:45 amRNSDirector/PDMR Shareholding
28th Sep 20214:15 pmRNSTransaction in Own Shares
21st Sep 20214:15 pmRNSTransaction in Own Shares
14th Sep 20214:30 pmRNSTransaction in Own Shares
7th Sep 20214:50 pmRNSTransaction in Own Shares
31st Aug 20214:50 pmRNSTransaction in Own Shares
31st Aug 20214:30 pmRNSDirector/PDMR Shareholding
31st Aug 20219:15 amRNSProsus increases stake in Delivery Hero
31st Aug 20219:15 amRNSProsus increases stake in Delivery Hero
31st Aug 20217:00 amRNSacquisition of 100% OF THE equity IN BillDesk
31st Aug 20217:00 amRNSacquisition of 100% OF THE equity IN BillDesk
26th Aug 20214:30 pmRNSDirectorate Change
26th Aug 20214:30 pmRNSDirectorate Change
25th Aug 20214:50 pmRNSAGM Statement
24th Aug 20214:50 pmRNSRESULTS OF ANNUAL GENERAL MEETING
23rd Aug 20217:30 amRNSProsus Share Repurchase Programme
23rd Aug 20217:30 amRNSShare Repurchase Programme
20th Aug 20214:45 pmRNSDirector/PDMR Shareholding
20th Aug 20214:45 pmRNSDirector/PDMR Shareholding
16th Aug 20217:00 amRNSSettlement Exchange Offer – AFM Notifications
16th Aug 20217:00 amRNSCapital Restructure and Exchange Offer Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.